SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (276)4/14/1998 12:47:00 PM
From: squetch  Read Replies (1) | Respond to of 717
 
ASCO 98 info

Gadolinium-texaphyrin radiation sensitizer: improved
survival in a phase IB/II trial in patients with brain
metastases.

Poster Discussion
Session: Central Nervous System
Date: May 19,1998
Time: 8:00 AM - 12:00 PM
Location: Room 404Ab/405